Persistência da veia marginal do embrião: relato de dois casos

PURPOSE: Congenital venous malformations of the lower limbs represent a particular challenge for the vascular surgeon. Persistence of fetal veins is a rare malformation, and the most common is the persistence of the lateral marginal vein usually observed in patients with Klippel-Trenaunnay Syndrome. The persistence of this embryonic vein as an isolated venous malformation without the other characteristics of the Klippel-Trenaunnay Syndrome has not yet been reported. This paper describes two cases. METHODS: Two patients, a 17-year-old male patient and a 16-year-old female, have had since their birth a large venous trunk in the lateral aspect of the right leg and thigh. The limbs underwent duplex scanning and phlebography. The surgical removal of the lateral marginal vein was performed. RESULTS: Surgical treatment resulted in very good functional and aesthetic results. Follow-up at 26 months showed no evidence of varicose vein recurrence. CONCLUSIONS: To achieve good results, surgical intervention may be indicated in cases of orthopedic deformity, hemorrhage, symptomatic, and unaesthetic lesions.OBJETIVO: As anomalias venosas congênitas representam um desafio especial para o cirurgião vascular. A persistência de veias fetais é uma malformação rara, sendo o exemplo mais comum a persistência da veia marginal embrionária na face lateral do membro inferior em pacientes com hemangiodisplasias complexas, particularmente a Síndrome de Klippel-Trenaunnay. Seu aparecimento como defeito vascular congênito único é raríssimo. Mostramos 2 destes casos. MÉTODO: Dois pacientes, com 17 e 16 anos sendo um do sexo masculino, apresentavam cordão varicoso, único e exuberante na face lateral da coxa e perna direita, presentes desde o nascimento. Os membros foram avaliados com mapeamento Duplex e flebografia. Foi realizado tratamento cirúrgico com ressecção total da veia marginal. RESULTADO: Ambos pacientes evoluíram satisfatoriamente. O seguimento médio foi de 26 meses, sem evidência de recorrência das varizes. CONCLUSÃO: A terapêutica nestes casos depende do estado clínico e extensão da lesão. As indicações para o tratamento cirúrgico incluem: sangramento, lesões tróficas, dor, edema e deformidade estética, obtendo-se bons resultados

Avaliação objetiva da isquemia de membros superiores: uso do dinamômetro isocinético

OBJECTIVE: The objective of this work is to present an objective, practical, and reproducible method for evaluating the functional limitation caused by occlusive arterial disease in upper limbs: a stress test using an isokinetic dynamometer. METHODS: Twenty-three patients with unilateral subclavian artery occlusive disease were included in the study, forming group 1. Seven patients of similar age, with atherosclerotic or Takayasu's disease in the aorto-iliac segment, without subclavian artery occlusive disease, were included as a control group (group 2). For all tests, we utilized the CYBEX© 6000 isokinetic dynamometer. The elbow was tested using a series of 30 repetitions of extension and flexion of the arm, performed up to a maximum of 270 repetitions (9 series) or until the limit of the tested limb was reached. RESULTS: We initially compared all the limbs without arterial disease of both groups to analyze whether they presented similar functional performance. No significant difference was found for any of the parameters studied. Considering that upper limbs without arterial disease have a similar response to exercise in these analyzed parameters, we compared the upper limbs in group 1 (with and without subclavian artery occlusive disease). For all parameters, the limbs with subclavian artery occlusive disease presented significantly lower values than the control limbs (P < 0.05), which can be objectively attributed to the ischemia (there were different responses in different individuals, which allows the quantification of the limitation caused by subclavian artery occlusive disease). CONCLUSION: In this study, we present a new stress test for impairment in patients with subclavian artery occlusive disease that might facilitate the classification of patients according to their functional impairment, and thus result in a better choice of therapeutic approach for each case as well as reporting of objective parameters that allow comparisons of the results of different treatments, including for long-term follow-up.OBJETIVO: O objetivo deste trabalho é apresentar um método para a avaliação da limitação funcional causada por doença arterial oclusiva de artéria subclávia: o teste de esforço utilizando o dinamômetro isocinético. MÉTODO: Pacientes com trombose unilateral de artéria subclávia foram selecionados, reunindo 23 pacientes no Grupo com doença arterial oclusiva de artéria subclávia. Sete pacientes com idade semelhante, sem doença arterial em membros superiores foram incluídos, formando o grupo controle. Para a realização do teste, utilizou-se o dinamômetro isocinético CYBEX® 6000. O cotovelo foi testado em séries consecutivas de 30 repetições do movimento de extensão e flexão, até que se atingisse o máximo de 270 repetições (9 séries), ou até que se alcançasse o limite do membro testado. RESULTADO: Inicialmente comparou-se todos os membros sem doença arterial dos dois grupos, para analisar se apresentavam desempenho semelhante. Não houve diferença estatística entre os grupos em relação a todos os parâmetros estudados. Comparou-se então, os dois membros de cada paciente do Grupo doença arterial oclusiva de artéria subclávia. Em todos os parâmetros analisados, os membros com doença arterial oclusiva de artéria subclávia apresentaram diferença estatística (p < 0.05) em relação aos membros controle, o que foi objetivamente atribuído à isquemia. (Foram registrados diferentes graus de limitação entre os paciente, o que permite estimar objetivamente o grau de limitação causado pela isquemia causada pela oclusão da subclávia) CONCLUSÃO: Este teste de esforço permite que pacientes com isquemia de membros superiores sejam avaliados e estratificados, conforme o grau de sua limitação funcional, o que facilitará a escolha da melhor terapêutica para cada caso e a obtenção de parâmetros para comparação do resultado de diferentes tratamentos e para o seguimento clínico em longo prazo

Tratamento endovascular para pacientes portadores de Claudicação Intermitente que não melhoram com tratamento clínico

PURPOSE: To study the results including long-term follow-up obtained with endovascular treatment of patients with intermittent claudication who did not experience clinical improvement with conservative treatment. METHODS: From January 1992 to January 2002, 62 of 1380 patients (4.5%) with intermittent claudication underwent endovascular treatment and were followed up for up to 120 months (mean 76 months). The variables analyzed were the functioning of the arterial segment undergoing the endovascular procedure, the evolution of the maximum walking distance, and incidence of related morbidity and mortality. RESULTS: Fifty-two patients (84%) experienced no walking limitation after the procedure, and 6 patients (10%) improved but still exhibited some degree of limitation, for a total improved outcome of 94%. The patency rate was 82%. There was no intraoperative mortality. One primary failure and one immediate thrombosis occurred, and both were surgically corrected. Thrombosis of the treated artery occurred in 6 patients 12, 16, 25, 29, 62, and 66 months after the procedure. These patients started to experience intermittent claudication with a walking distance to onset that was similar to their presurgical distance to onset. During follow-up, a mortality rate of 12.9% (8 patients) was observed, 6 due to myocardial infarctions and 2 due cerebral infarction. Three patients underwent coronary bypasses 22, 36, and 55 months after the endovascular surgery, and 2 patients underwent coronary angioplasty after 6 and 26 months. The mean follow up period was 76 months (range 0-120 months). CONCLUSION: This study shows that endovascular treatment of intermittent claudication brought about a lasting regression of the ischemic conditions in a significant number of patients, with excellent patency rates. It was concluded that this is a good alternative for selected patients, with low rates of complications and positive long-term results.OBJETIVO: Estudar a longo prazo (média de 76 meses de seguimento) os resultados obtidos com o tratamento endovascular em pacientes que não melhoram com o tratamento clínico, MÉTODOS: De Janeiro de 1992 a Janeiro de 2002, 62 pacientes de um grupo de 1380 claudicantes foram submetidos a tratamento endovascular, representando 4,5% do total. As variáveis analisadas foram o funcionamento do segmento arterial submetido ao procedimento endovascular, a evolução da distância máxima de marcha e a ocorrência de morbi-mortalidade. RESULTADOS: Cinqüenta e dois (84%) pacientes não apresentaram restrições à deambulação após o procedimento. Seis pacientes melhoraram, representando um benefício de 94%. Não houve mortalidade intra-operatória. Uma falência primária e uma trombose imediata foram corrigidas cirurgicamente. Seis pacientes apresentaram trombose da artéria tratada 12, 16, 25, 29, 62 e 66 meses após o procedimento e voltaram a apresentar Claudicação Intermitente para as mesmas distâncias referidas antes da cirurgia. Durante o seguimento foi observada taxa de mortalidade de 12,9% (8 pacientes), dos quais 6 por infarto do miocárdio e dois por acidente vascular cerebral. Três pacientes foram submetidos à revascularização miocárdica 22, 36 e 55 meses após o procedimento endovascular e duas angioplastias foram realizadas com 6 e 26 meses de seguimento. O tempo médio de segmento foi de 76 meses (0 a 120 meses). CONCLUSÃO: O tratamento endovascular da Claudicação Intermitente levou a melhora das condições da marcha em um número significativo de pacientes, com excelentes taxas de patência (82,0%). Concluímos que esta é uma boa alternativa para determinados pacientes, com poucas complicações e resultados positivos a longo prazo

Endovascular treatment for intermittent claudication in patients who do not improve with clinical treatment

PURPOSE: To study the results including long-term follow-up obtained with endovascular treatment of patients with intermittent claudication who did not experience clinical improvement with conservative treatment. METHODS: From January 1992 to January 2002, 62 of 1380 patients (4.5%) with intermittent claudication underwent endovascular treatment and were followed up for up to 120 months (mean 76 months). The variables analyzed were the functioning of the arterial segment undergoing the endovascular procedure, the evolution of the maximum walking distance, and incidence of related morbidity and mortality. RESULTS: Fifty-two patients (84%) experienced no walking limitation after the procedure, and 6 patients (10%) improved but still exhibited some degree of limitation, for a total improved outcome of 94%. The patency rate was 82%. There was no intraoperative mortality. One primary failure and one immediate thrombosis occurred, and both were surgically corrected. Thrombosis of the treated artery occurred in 6 patients 12, 16, 25, 29, 62, and 66 months after the procedure. These patients started to experience intermittent claudication with a walking distance to onset that was similar to their presurgical distance to onset. During follow-up, a mortality rate of 12.9% (8 patients) was observed, 6 due to myocardial infarctions and 2 due cerebral infarction. Three patients underwent coronary bypasses 22, 36, and 55 months after the endovascular surgery, and 2 patients underwent coronary angioplasty after 6 and 26 months. The mean follow up period was 76 months (range 0-120 months). CONCLUSION: This study shows that endovascular treatment of intermittent claudication brought about a lasting regression of the ischemic conditions in a significant number of patients, with excellent patency rates. It was concluded that this is a good alternative for selected patients, with low rates of complications and positive long-term results